Kit for detecting mycobacterium tuberculosis based on blood free nucleic acid
A technology of Mycobacterium tuberculosis and free nucleic acid is applied in the field of test kits for detecting Mycobacterium tuberculosis, which can solve the problems of low diagnosis rate of sputum samples, delayed patient treatment time, low sensitivity, etc., so as to avoid crossover between multiple pathogens. The effect of reaction, avoiding the generation of non-specific amplification products, and reducing the safety risk factor
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0042] Example 1
[0043] This embodiment provides a kit (PCR-fluorescent probe method) for detecting Mycobacterium tuberculosis based on free nucleic acid in blood, which includes PCR reaction solution, primers, enzymes, internal standards, quality control samples, and detection of MTB target nucleosides Acid fluorescent probe, detection internal standard fluorescent probe, positive quality control product and negative control product, primers include detection MTB target nucleotide primer and detection internal standard primer, and detect the nucleotide sequence of MTB target nucleotide primer As shown in SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4 (2 pairs of primers);
[0044] The internal standard is a plasmid whose nucleotide sequence is as shown in SEQ ID NO.7, and the plasmid concentration is 2×10 4 copies / ml, the nucleotide sequence of the detection internal standard primer is shown in SEQ ID NO.5 and SEQ ID NO.6;
[0045] The PCR reaction solution includes the f...
Example Embodiment
[0082] Example 2
[0083] This embodiment provides a kit for detecting Mycobacterium tuberculosis based on free nucleic acid in blood (PCR-membrane chromatography hybridization method), which includes PCR reaction solution, primers, enzymes, internal standards, hybridization membrane strips, color developing solution, Positive quality control product and negative quality control product, with hybridization probe attached to the hybridization membrane strip;
[0084] The internal standard is a plasmid whose nucleotide sequence is shown in SEQ ID NO.7, and the plasmid concentration is 2×10 4 copies / ml, the nucleotide sequence of the detection internal standard primer is shown in SEQ ID NO.5, SEQ ID NO.6, and the 5'end of the upstream primer of the detection internal standard primer is also connected to the C3 spacer (C3spacer ) And the first tag sequence, the first tag sequence is shown in SEQ ID NO. 15; the 5'end of the downstream primer of the detection internal standard primer is ...
Example Embodiment
[0122] Example 3
[0123] This example uses the reagent kits of Examples 1 to 2 and the sputum smear method to detect clinical samples. The actual situation of the clinical samples is: 103 cases of tuberculosis, 26 cases of extrapulmonary tuberculosis, 43 cases of negative cases, and a total of 172 cases ; The results of the two kits (PCR-fluorescent probe method and PCR-membrane chromatography hybridization method) in this example are as follows figure 2 As shown, and compared with the sputum smear method, the comparison results are shown in Table 6; Note: Table 6 is the sputum smear test results when viewed vertically, and the test results of the two kits of the present invention when viewed horizontally; the following table views similar.
[0124] Table 6
[0125]
[0126]
[0127] As shown in Table 6, the overall positive and negative rates of the sputum smear method were 20.93% (36 / 172) and 79.07% (136 / 172), respectively. The positive rates of tuberculosis patients and extra-p...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap